TScan Therapeutics, Inc. (TCRX)
Market Open
26 Oct, 07:43 PM
NASDAQ (NMS) NASDAQ (NMS) Primary $
0. 19
-0.02
-8.5138%
$
14.67M Market Cap
- P/E Ratio
- Div Yield
763,740 Volume
-1.04 Eps
$ 0.2
Previous Close 
Want to track TCRX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
TScan Therapeutics, Inc. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
 John H. Burbank III Passport Capital LLC | 2.78M | $16.16M | $520,477.62 | -$15.64M | -96.78% |
| SR Scott Ring Deer Management Co. LLC | 1.25M | $5.6M | $226,806.28 | -$5.38M | -95.95% |
 Kyle P. Smith NewEdge Wealth LLC | 91,463 | $141,767.65 | $16,993.83 | -$124,773.82 | -88.01% |
 Dinan Hu R Squared Ltd | 18,360 | $17,995 | $3,818.88 | -$14,176.12 | -78.78% |
 Hui Fai Tam Caitong International Asset Management Co. Ltd. | 1 | $1 | $0.19 | -$0.81 | -81% |
 Alexandra Stickelman Root Financial Partners, LLC | 85 | $27 | $19.04 | -$7.96 | -29.48% |
2026 © Marketlog. All Rights Reserved.
